i-Sens is engaged in the development, manufacturing, and sales of chemical and biosensors, including glucometers and point-of-care diagnostic devices, based on electrochemical technology and biosensor technology. The main business segments consist of the "Glucometer Division," which allows anyone, whether diabetic or not, to measure their blood glucose levels themselves, and the "Point-of-Care Diagnostics Division," which focuses on diagnostic equipment for hospitals.

The CareSens® family of products helps you incorporate blood glucose testing into your daily lives by delivering fast, highly accurate results. i-SENS launched ‘CareSens®’ Blood Glucose Monitoring System in 2003 with the world’s first technology which measures blood glucose level using 0.5 μL blood sample within 5 seconds. Since then, i-SENS has strengthened its CareSens® brand by continuously developing and launching CareSens® series with its advanced technology. i-SENS BGMS continues to meet the stringent quality requirements of international standards. CareSens® S Fit was recently cleared by the FDA. It complies with ISO 15197:2013/EN ISO 15197:2015 international standard and new FDA standards.

Public

Diagnostic